Steam Ablation, Great Saphenous Ablation Versus Foam, Small Saphenous Compared to Great- Ablation, Intraluminal Blood, Endothelin Release, Follow Up of RadioFrequency, Saphenous Vein Diameter (CONG2011-16)
Steps to Successfully Complete This Activity
To participate in this educational activity please follow the steps listed below.
If you are new to the ACP Online Education Center we require that you register prior to viewing any activity. Click the Register link located in the top right corner of this screen to do so. If you are already a registered user log in and click the TAKE COURSE button that will appear in the Course Summary box.
- To begin the activity click the START COURSE button.
- Progress through course content by using the NEXT button.
- Complete all required items in the course.
- Track your progress using the Course Progress menu.
- On the final page of the activity a link will be provided to download your certificate.
The content of this activity is designed to meet the needs of the following target audience: phlebologists, general surgeons, vascular surgeons, interventional radiologists, interventional cardiologists, vascular medicine practitioners, dermatologists, dermatologic surgeons, family practice and internal medicine practitioners, plastic surgeons, obstetricians and gynecologists, cardiologists, and any other healthcare professional currently or planning on treating patients with venous disease.
- Rene Milleret, MD, would like to disclose being a Consultant for Cerma- Vein. The SVS Device is not FDA approved (510K pending).It has a CE Certificate since Nov 2008.
- Khaled ElKaffas, MD, has nothing to disclose.
- Mikel Sadek, MD, has nothing to disclose.
- Marc Vuylsteke, MD, would like to disclose that this trial has been funded by Bard Benelux, Hospithera, Sanofi- Aventis and Maquet vascular interventions. These sponsors do not have any involvement (except sponsoring) in this study. Tulip fibers, as referred to in this talk, are not FDA approved. Otherwise, there is no conflict of interest.
- Alessandro Frullini, MD, provides disclosure of non- FDA approved drugs: Polidocanol foam, as referred to in this talk - has not been approved for use by the Federal Drug Administration (FDA). He would also like to disclose conflicts of Interest, as Consultant for GLORIA MED.
- Thomas Proebstle, MD, MSc, discloses that he is the Clinical Investigator, and Speaker for Sapheon, as well as owning stock. For Covidien, he is the Clinical Investigator, Consultant, and Speaker. He also discloses that he is the Speaker for CoolTouch.
- Tristin Lane, MD, has nothing to disclose.
The views and opinions expressed in this activity are those of the faculty and do not necessarily represent the views of the ACP. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting professional use of any of the information provided herein. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ACP Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Discussion of Off-Label Use
Although no longer required by the Accreditation Council for Continuing Medical Education (ACCME), ACP CME requests all faculty to inform learners of any products they will discuss that are off-label or investigational.
Reproduction of this material is not permitted without written permission from the copyright owner.